Cuffed and uncuffed tracheal tube in children
Editor-We read with interest the article by Weiss and colleagues 1 regarding the use of cuffed or uncuffed endotracheal tubes. Although this was once a hotly contested debate, we find that more and more centres are switching to the use of cuffed tubes in younger children and infants. Our experience has been the same and the validation of these data in a large prospective randomized trial only confirms our belief that this is indeed safe. One main advantage of the use of the cuffed tube is the absence of the multiple intubation attempts to change the tracheal tube when a significant leak is observed. The micro-cuff may be an additional benefit that we now have over the conventional cuffs. We fully endorse the authors' view that cuffed tracheal tubes can be used safely in children. Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock
Editor-Beta-adrenergic blockers and positive inotropic therapies are considered alternative strategies for the management of patients with heart failure. 1 Inotropes improve haemodynamics, but have been associated with an increased risk of death and cardiac events 2 3 with the possible exception of levosimendan. 4 We recently treated a patient with acute myocardial infarction (AMI) complicated by cardiogenic shock with simultaneous continuous infusion of levosimendan and esmolol.
A 56-yr-old male had a massive anterior AMI at 6 a.m. on a cruise. Onboard thrombolysis reduced the ST segment elevation. At 7:45 a.m., the patient was transported to the nearest hospital where clinical examination showed: arterial pressure (AP) 70/40, heart rate (HR) 145 beats min 21 , central venous pressure (CVP) 16 mm Hg, and peripheral oxygen saturation (Sp O 2 ) 88%. Echocardiography showed an ejection fraction (EF) ,20%, a restrictive diastolic pattern (the E/E 0 ratio . 13 and the E/V p ratio . 
